Healthcare -
Biotechnology - NASDAQ - GB
$ 0.86
-1.15 %
$ 5.22 K
Market Cap
-0.33
P/E
AKTX - STOCK-BASED COMPENSATION
Stock-based Compensation AKTX - Akari Therapeutics, Plc
1.15 M
LAST VALUE
91.18%
2 YEAR CAGR
-6.95%
5 YEAR CAGR
28.46%
10 YEAR CAGR